Contact
DMCA
Privacy
Robuta
https://www.medsciencescapital.com/news/prosensa-begins-nda-submission-to-the-fda-for-exon-skipping-drug-drisapersen-to-treat-duchenne-muscular-dystrophy/
Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne...
exon skipping
prosensa
begins
nda
submission
https://www.jci.org/articles/view/117052/scanned-page/1041
JCI - Identification of a novel exonic mutation at -13 from 5' splice site causing exon skipping in...
jci
identification
novel
exonic
mutation
https://www.mdpi.com/2673-5261/6/1/5
Challenges in Amplicon-Based DNA NGS Identification of MET Exon 14 Skipping Events in Non-Small...
Introduction: MET Exon 14 skipping alterations are drivers of non-small cell lung carcinoma (NSCLC) with responses to tyrosine kinase inhibitors....
challenges
amplicon
based
dna
ngs